This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Jan 12;381(9861):111-2.

doi: 10.1016/S0140-6736(13)60041-0.

Early bactericidal activity of new drug regimens for tuberculosis

Robert S Wallis, Carol Nacy

PMID: 23312744
DOI: 10.1016/S0140-6736(13)60041-0

Comment

Early bactericidal activity of new drug regimens for tuberculosis

Robert S Wallis et al. Lancet. 2013.

. 2013 Jan 12;381(9861):111-2.

doi: 10.1016/S0140-6736(13)60041-0.

Authors

Robert S Wallis, Carol Nacy

PMID: 23312744
DOI: 10.1016/S0140-6736(13)60041-0

No abstract available

PubMed Disclaimer

Comment in

Early bactericidal activity of new drug regimens for tuberculosis - Authors' reply.
Diacon AH, Donald PR, Mendel CM. Diacon AH, et al. Lancet. 2013 Jan 12;381(9861):112-3. doi: 10.1016/S0140-6736(13)60042-2. Lancet. 2013. PMID: 23312747 No abstract available.

Comment on

14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial.
Diacon AH, Dawson R, von Groote-Bidlingmaier F, Symons G, Venter A, Donald PR, van Niekerk C, Everitt D, Winter H, Becker P, Mendel CM, Spigelman MK. Diacon AH, et al. Lancet. 2012 Sep 15;380(9846):986-93. doi: 10.1016/S0140-6736(12)61080-0. Epub 2012 Jul 23. Lancet. 2012. PMID: 22828481 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations